Shareholder Alert: Centene Corporation Class Action Lawsuit Update

Centene Corporation's shareholders were left with significant financial losses after the company issued a press release withdrawing its 2025 guidance, citing lower-than-expected overall market growth across 22 states. The decline in stock price was swift, with shares plummeting 40.4% from $56.65 to $33.78 on July 2, 2025. The Gross Law Firm is encouraging shareholders who purchased Centene shares during the class period (December 12, 2024 to June 30, 2025) to contact the firm regarding possible lead plaintiff appointment.

Key Takeaways:

• The Gross Law Firm is seeking recovery for investors who incurred losses due to false and/or misleading statements by Centene Corporation regarding its enrollment and morbidity rates.
• Centene's overall market growth across 22 states was lower than expected, leading to a reduction in its 2025 guidance to approximately $1.8 billion or an adjusted diluted EPS of $2.75.
• The company's stock price fell dramatically from $56.65 to $33.78 on July 2, 2025, a decline of 40.4%.
• Shareholders who purchased Centene shares during the class period (December 12, 2024 to June 30, 2025) are encouraged to contact the Gross Law Firm regarding possible lead plaintiff appointment.
• There is no cost or obligation to participate in the case, and the deadline to seek to be a lead plaintiff is September 8, 2025.
• The Gross Law Firm is a nationally recognized class action law firm with a mission to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices.

Statistics:

• 40.4% decline in Centene's stock price from $56.65 to $33.78 on July 2, 2025
• 22 states experienced lower-than-expected overall market growth
• $1.8 billion reduction in Centene's 2025 guidance
• Adjusted diluted EPS of $2.75 for 2025
• 40.4% decline in stock price represents a significant loss for investors
• Number of states experiencing lower-than-expected market growth is significant